Editorial: New Insights Into Understanding and Managing NAFLD
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-11-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.777740/full |
| _version_ | 1818989674638606336 |
|---|---|
| author | Óscar Escribano Daniel E. Francés Yolanda F. Otero Javier Egea Águeda González-Rodríguez Águeda González-Rodríguez |
| author_facet | Óscar Escribano Daniel E. Francés Yolanda F. Otero Javier Egea Águeda González-Rodríguez Águeda González-Rodríguez |
| author_sort | Óscar Escribano |
| collection | DOAJ |
| first_indexed | 2024-12-20T19:42:14Z |
| format | Article |
| id | doaj.art-4c97ba08c41c4bbcb9f097108729372a |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-12-20T19:42:14Z |
| publishDate | 2021-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-4c97ba08c41c4bbcb9f097108729372a2022-12-21T19:28:30ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-11-01810.3389/fmed.2021.777740777740Editorial: New Insights Into Understanding and Managing NAFLDÓscar Escribano0Daniel E. Francés1Yolanda F. Otero2Javier Egea3Águeda González-Rodríguez4Águeda González-Rodríguez5Laboratory of Hepatic and Cardiovascular Diseases, Biochemistry and Molecular Biology Department, School of Pharmacy, Complutense University of Madrid, Madrid, SpainInstituto de Fisiología Experimental (IFISE-CONICET), Rosario, ArgentinaValbiotis, Riom, FranceMolecular Neuroinflammation and Neuronal Plasticity Research Laboratory, Research Unit, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, Madrid, SpainMetabolic Syndrome and Vascular Risk Research Laboratory, Research Unit, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, Madrid, SpainCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spainhttps://www.frontiersin.org/articles/10.3389/fmed.2021.777740/fullNAFLD (non-alcoholic fatty liver disease)biomarkerstherapeutical approachesliver pathophysiologysteatohepatitis |
| spellingShingle | Óscar Escribano Daniel E. Francés Yolanda F. Otero Javier Egea Águeda González-Rodríguez Águeda González-Rodríguez Editorial: New Insights Into Understanding and Managing NAFLD Frontiers in Medicine NAFLD (non-alcoholic fatty liver disease) biomarkers therapeutical approaches liver pathophysiology steatohepatitis |
| title | Editorial: New Insights Into Understanding and Managing NAFLD |
| title_full | Editorial: New Insights Into Understanding and Managing NAFLD |
| title_fullStr | Editorial: New Insights Into Understanding and Managing NAFLD |
| title_full_unstemmed | Editorial: New Insights Into Understanding and Managing NAFLD |
| title_short | Editorial: New Insights Into Understanding and Managing NAFLD |
| title_sort | editorial new insights into understanding and managing nafld |
| topic | NAFLD (non-alcoholic fatty liver disease) biomarkers therapeutical approaches liver pathophysiology steatohepatitis |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2021.777740/full |
| work_keys_str_mv | AT oscarescribano editorialnewinsightsintounderstandingandmanagingnafld AT danielefrances editorialnewinsightsintounderstandingandmanagingnafld AT yolandafotero editorialnewinsightsintounderstandingandmanagingnafld AT javieregea editorialnewinsightsintounderstandingandmanagingnafld AT aguedagonzalezrodriguez editorialnewinsightsintounderstandingandmanagingnafld AT aguedagonzalezrodriguez editorialnewinsightsintounderstandingandmanagingnafld |